Physician

Kanishka Chakraborty, M.D

According to 2025 Medicare claims, Kanishka Chakraborty, M.D (NPI: 1992993760) practices medical oncology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is TENNESSEE CANCER SPECIALISTS PLLC (NPI: 1841228871; TIN: 200677400) and primary practice location at 37660-7435. Chakraborty is affiliated with the AnewCare Collaborative, LLC (ACO ID: A1241), participating under the MSSP model.

Chakraborty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 326 traditional Medicare patients, billed 22,890 HCPCS/CPT codes, and received $401,682 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,352 prescription claims across 211 beneficiaries totaling $2,904,223 in drug costs, led by Ayvakit (Avapritinib). DME data shows 24 claims. Open Payments data shows 58 records totaling $1,293. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $43,736 to $401,682. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $408,791 to $2,904,223. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,625 and ending at $2,087.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	307	722	$43,736
2016	297	678	$55,097
2017	308	721	$66,797
2018	280	659	$56,503
2019	240	644	$47,547
2020	243	639	$54,066
2021	240	1,028	$125,615
2022	227	627	$71,103
2023	224	499	$48,884
2024	326	22,890	$401,682

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	1,151	$408,791
2016	173	1,268	$534,420
2017	171	1,074	$747,184
2018	164	1,004	$961,524
2019	160	1,085	$789,521
2020	184	1,372	$1,418,808
2021	221	1,704	$1,967,580
2022	206	1,632	$2,374,920
2023	208	1,492	$2,294,123
2024	211	1,352	$2,904,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$970
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	24	$1,018
2020	N/R	24	$1,324
2021	N/R	40	$1,936
2022	N/R	13	$614
2023	N/R	N/R	N/R
2024	N/R	24	$1,317

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	56	56	$152
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	198	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	189	209	$85
36415	Insertion of needle into vein for collection of blood sample	76	169	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	70	157	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ayvakit	Avapritinib	11	330	$430,382
Calquence	Acalabrutinib Maleate	30	900	$369,199
Lenalidomide	Lenalidomide	31	826	$363,933
Xalkori	Crizotinib	15	420	$301,420
Ibrance	Palbociclib	17	476	$269,881

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$891
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$426

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,293	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kanishka Chakraborty, M.D?

Tedicare shows public-source Medicare data for Kanishka Chakraborty, M.D (NPI 1992993760), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kanishka Chakraborty, M.D have ACO affiliation data?

Kanishka Chakraborty, M.D is shown with ACO affiliation data for AnewCare Collaborative, LLC (MSSP, ACO ID A1241).

What billing organization is linked to Kanishka Chakraborty, M.D?

Kanishka Chakraborty, M.D is linked to TENNESSEE CANCER SPECIALISTS PLLC (billing NPI 1841228871) in the available physician profile data.

Does Kanishka Chakraborty, M.D have Open Payments data?

Kanishka Chakraborty, M.D has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.